| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.097 | 0.001 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |